{"id":"https://openalex.org/W65335468","doi":"https://doi.org/10.33588/rn.3605.2002416","title":"Tolerancia y acontecimientos adversos del tratamiento con inhibidores de la acetilcolinesterasa en una muestra cl\u00ednica de pacientes con enfermedad de Alzheimer de gravedad m\u00ednima y leve durante un per\u00cdodo de seis meses","display_name":"Tolerancia y acontecimientos adversos del tratamiento con inhibidores de la acetilcolinesterasa en una muestra cl\u00ednica de pacientes con enfermedad de Alzheimer de gravedad m\u00ednima y leve durante un per\u00cdodo de seis meses","publication_year":2003,"publication_date":"2003-01-01","ids":{"openalex":"https://openalex.org/W65335468","doi":"https://doi.org/10.33588/rn.3605.2002416","mag":"65335468","pmid":"https://pubmed.ncbi.nlm.nih.gov/12640593"},"language":"es","primary_location":{"id":"doi:10.33588/rn.3605.2002416","doi":"https://doi.org/10.33588/rn.3605.2002416","is_oa":false,"landing_page_url":"https://doi.org/10.33588/rn.3605.2002416","pdf_url":null,"source":{"id":"https://openalex.org/S184263677","display_name":"Revista de Neurolog\u00eda","issn_l":"0210-0010","issn":["0210-0010","1576-6578"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","ki-jl-1","medline","norway-1","poland-20","russia-white-list-3"],"host_organization":"https://openalex.org/P4322632785","host_organization_name":"Viguera Publishers","host_organization_lineage":["https://openalex.org/P4322632785"],"host_organization_lineage_names":["Viguera Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Revista de Neurolog\u00eda","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5086704325","display_name":"Antoni Turon Estrada","orcid":"https://orcid.org/0000-0003-3784-7435","observed_orcids":["https://orcid.org/0000-0003-3784-7435"]},"institutions":[{"id":"https://openalex.org/I4210121211","display_name":"Hospital Santa Caterina","ror":"https://ror.org/036dkm174","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210121211"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Antoni Turon Estrada","raw_affiliation_strings":["Unitat de Valoraci\u00f3 de la Mem\u00f2ria i les Dem\u00e8ncies (UVAMID), Hospital Santa Caterina, Girona, Espa\u00f1a"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Unitat de Valoraci\u00f3 de la Mem\u00f2ria i les Dem\u00e8ncies (UVAMID), Hospital Santa Caterina, Girona, Espa\u00f1a","institution_ids":["https://openalex.org/I4210121211"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012336996","display_name":"Secundino L\u00f3pez Pousa","orcid":"https://orcid.org/0000-0002-2818-3473","observed_orcids":["https://orcid.org/0000-0002-2818-3473"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Secundino L\u00f3pez Pousa","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022389058","display_name":"Esther Gelada-Batlle","orcid":"https://orcid.org/0000-0002-9214-652X","observed_orcids":["https://orcid.org/0000-0002-9214-652X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Esther Gelada Batlle","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051947155","display_name":"Josep Garre\u2010Olmo","orcid":"https://orcid.org/0000-0002-7817-0814","observed_orcids":["https://orcid.org/0000-0002-7817-0814"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Josep Garre Olmo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109201211","display_name":"Manuela Lozano Gallego","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Manuela Lozano Gallego","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110390703","display_name":"Marta Hern\u00e1ndez-Ferr\u00e0ndiz","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marta Hern\u00e1ndez Ferr\u00e0ndiz","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013871714","display_name":"Cristina Fajardo Tibau","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Cristina Fajardo Tibau","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113520478","display_name":"Ver\u00f2nica Morante Mu\u00f1oz","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ver\u00f2nica Morante Mu\u00f1oz","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5038802405","display_name":"Joan Vilalta Franch","orcid":"https://orcid.org/0000-0002-5306-437X","observed_orcids":["https://orcid.org/0000-0002-5306-437X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joan Vilalta Franch","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.9646,"has_fulltext":false,"cited_by_count":18,"citation_normalized_percentile":{"value":0.73119456,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":"36","issue":"05","first_page":"421","last_page":"421"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.8446999788284302,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.8446999788284302,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.13850000500679016,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.008700000122189522,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/acetylcholinesterase-inhibitors","display_name":"acetylcholinesterase inhibitors","score":0.9819999933242798},{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.8889999985694885},{"id":"https://openalex.org/keywords/donepezil","display_name":"donepezil","score":0.9620000123977661},{"id":"https://openalex.org/keywords/rivastigmine","display_name":"rivastigmine","score":1.0},{"id":"https://openalex.org/keywords/drug-tolerance","display_name":"drug tolerance","score":0.6539999842643738},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.8370000123977661},{"id":"https://openalex.org/keywords/gastrointestinal-diseases","display_name":"gastrointestinal diseases","score":0.9700000286102295},{"id":"https://openalex.org/keywords/treatment-discontinuation","display_name":"treatment discontinuation","score":0.8529999852180481},{"id":"https://openalex.org/keywords/mild-alzheimer-s-disease","display_name":"mild Alzheimer's disease","score":0.625},{"id":"https://openalex.org/keywords/dose-adjustment","display_name":"dose adjustment","score":0.5619999766349792}],"concepts":[{"id":"https://openalex.org/C2776332859","wikidata":"https://www.wikidata.org/wiki/Q411887","display_name":"Rivastigmine","level":5,"score":0.9679967164993286},{"id":"https://openalex.org/C2780904820","wikidata":"https://www.wikidata.org/wiki/Q415081","display_name":"Donepezil","level":4,"score":0.9534521698951721},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.784244179725647},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6612705588340759},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.49235260486602783},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.39510226249694824},{"id":"https://openalex.org/C2779483572","wikidata":"https://www.wikidata.org/wiki/Q83030","display_name":"Dementia","level":3,"score":0.3677981197834015},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.2617698609828949},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C120665830","wikidata":"https://www.wikidata.org/wiki/Q14620","display_name":"Optics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000068836","descriptor_name":"Rivastigmine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077265","descriptor_name":"Donepezil","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002219","descriptor_name":"Carbamates","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D002219","descriptor_name":"Carbamates","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002800","descriptor_name":"Cholinesterase Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D002800","descriptor_name":"Cholinesterase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005767","descriptor_name":"Gastrointestinal Diseases","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007189","descriptor_name":"Indans","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D007189","descriptor_name":"Indans","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D048448","descriptor_name":"Phenylcarbamates","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.33588/rn.3605.2002416","doi":"https://doi.org/10.33588/rn.3605.2002416","is_oa":false,"landing_page_url":"https://doi.org/10.33588/rn.3605.2002416","pdf_url":null,"source":{"id":"https://openalex.org/S184263677","display_name":"Revista de Neurolog\u00eda","issn_l":"0210-0010","issn":["0210-0010","1576-6578"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","ki-jl-1","medline","norway-1","poland-20","russia-white-list-3"],"host_organization":"https://openalex.org/P4322632785","host_organization_name":"Viguera Publishers","host_organization_lineage":["https://openalex.org/P4322632785"],"host_organization_lineage_names":["Viguera Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Revista de Neurolog\u00eda","raw_type":"journal-article"},{"id":"pmid:12640593","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12640593","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Revista de neurologia","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4367484415","https://openalex.org/W170237590","https://openalex.org/W2032734052","https://openalex.org/W2468914478","https://openalex.org/W2729777670","https://openalex.org/W2026566053","https://openalex.org/W2912402341","https://openalex.org/W61648805","https://openalex.org/W2414565701","https://openalex.org/W2772086940"],"abstract_inverted_index":{"INTRODUCTION:":[0],"At":[1],"present":[2],"acetylcholinesterase":[3],"inhibitors":[4],"(AChEI)":[5],"are":[6,27,197],"used":[7],"in":[8,32,71,183,208],"the":[9,12,30,43,47,61,64,118,125,131,139,145,149,156,172,184,198],"treatment":[10,203],"of":[11,24,60,68,74,94,97,106,114,117,138,148,155,169,175],"cognitive":[13],"deterioration":[14],"associated":[15,192],"with":[16,29,76,102,110,142,159,163,187,195,211],"Alzheimer":[17],"s":[18],"disease":[19],"(AD).":[20],"The":[21,89,190],"side":[22],"effects":[23],"these":[25],"drugs":[26],"linked":[28],"increase":[31],"acetylcholine,":[33],"which":[34,98],"limits":[35],"their":[36],"effectiveness,":[37],"and":[38,63,79,108,122,171,204],"must":[39],"be":[40],"adjusted":[41],"to":[42,46,153,193],"patient":[44],"close":[45],"maximum":[48],"tolerated":[49],"dose.":[50],"PATIENTS":[51],"AND":[52],"METHODS:":[53],"We":[54],"conducted":[55],"a":[56,72,84,166],"comparative":[57],"retrospective":[58],"study":[59],"tolerance":[62],"adverse":[65],"events":[66],"(AE)":[67],"two":[69],"AChEI":[70,196],"group":[73],"patients":[75,119,140,157,185,209],"very":[77],"slight":[78],"mild":[80],"probable":[81],"AD":[82],"over":[83],"6":[85,111],"month":[86],"period.":[87],"RESULTS:":[88],"sample":[90],"was":[91,178],"made":[92],"up":[93],"175":[95],"patients,":[96],"134":[99],"began":[100],"therapy":[101,146,194],"5":[103],"10":[104],"mg/day":[105,113],"donepezil":[107,143],"41":[109],"12":[112],"rivastigmine.":[115,160,212],"20%":[116],"presented":[120],"AE":[121,133,150],"8%":[123],"abandoned":[124,144],"treatment.":[126],"Gastrointestinal":[127],"disorders":[128],"(GID)":[129],"were":[130],"main":[132,199],"observed":[134],"(57.1%).":[135],"Only":[136],"6%":[137],"treated":[141,158,162,186,210],"because":[147],"as":[151],"opposed":[152],"14.6%":[154],"Patients":[161],"rivastigmine":[164],"displayed":[165],"higher":[167,181],"incidence":[168],"GID":[170,177,191],"relative":[173],"risk":[174],"presenting":[176],"4.4":[179],"times":[180],"than":[182],"donepezil.":[188],"CONCLUSIONS:":[189],"reason":[200],"for":[201],"abandoning":[202],"occur":[205],"more":[206],"frequently":[207]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":2},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}